UPPER RESPIRATORY INFECTION VIRAL

Clinical trials for UPPER RESPIRATORY INFECTION VIRAL explained in plain language.

Never miss a new study

Get alerted when new UPPER RESPIRATORY INFECTION VIRAL trials appear

Sign up with your email to follow new studies for UPPER RESPIRATORY INFECTION VIRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug fights common cold to protect vulnerable lungs

Disease control Completed

This study tested an experimental drug called vapendavir to see if it could reduce serious lung symptoms in people with COPD after they caught a common cold virus. Researchers gave the drug or a placebo to 52 adults with moderate COPD who were then exposed to the virus. The main …

Matched conditions: UPPER RESPIRATORY INFECTION VIRAL

Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

UPPER RESPIRATORY INFECTION VIRAL

Get alerted when new UPPER RESPIRATORY INFECTION VIRAL trials appear

New drug fights common cold to protect vulnerable lungs